Flexible Leave Act

The Flexible Leave Act (HR7505) was introduced in the House on February 11, 2026, and has been referred to the Committees on Education and Workforce, Oversight and Government Reform, and House Administration. This bill seeks to amend the Family and Medical Leave Act of 1993 to permit all leave to be taken on an intermittent schedule and, notably, removes the certification requirement for intermittent leave. This is an early-stage bill with one sponsor and one cosponsor, indicating it has a long legislative path ahead. This bill does not authorize or appropriate any direct funding. Its impact is regulatory, potentially increasing operational costs and administrative burdens for employers by expanding the scope and ease of intermittent FMLA leave. The lack of a certification requirement could lead to more frequent and less predictable intermittent leave usage, requiring businesses to adjust staffing and operational planning without direct financial compensation or support from the government. Structural losers from this legislation, should it pass in its current form, would be large employers across various sectors that are subject to FMLA regulations. This includes companies like Walmart ($WMT), Amazon ($AMZN), Microsoft ($MSFT), JPMorgan Chase ($JPM), and UnitedHealth Group ($UNH). These companies, with their large workforces, would face increased administrative overhead and potential productivity disruptions. There are no clear structural winners from this bill, as its primary effect is to expand employee leave flexibility at the employer's expense. Despite the potential for increased costs, the market has not reacted negatively to the introduction of HR7505. Over the last 7 days, Walmart ($WMT) has seen a +0.35% change, Amazon ($AMZN) a +1.77% change, Microsoft ($MSFT) a +0.04% change, and UnitedHealth Group ($UNH) a significant +12.42% change. JPMorgan Chase ($JPM) experienced a slight decrease of -0.18%. These price movements suggest that the market is either unaware of the bill, views its chances of passage as low, or believes the impact would be negligible for these large, diversified companies. The bill's early stage and referral to multiple committees mean that significant legislative steps, including committee hearings, potential amendments, and votes in both chambers, remain. The bill was introduced on February 11, 2026, and immediately referred to three committees. This indicates the initial procedural steps have been taken, but there has been no further action since its introduction. The next steps would involve committee consideration, which could include hearings and markups, before potentially moving to a floor vote in the House.